41

OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Embed Size (px)

Citation preview

Page 1: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 2: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

OUTLINE:I. Historical Perspective. A. Development of Thromboelastography.

B. The expansion and transition from Cardiac Surgery to Trauma.

II. Traditional Lab Tests vs. TEG tests.A. Clotting cascade B. Traditional Testing

1. Protime( (PT) 2. Partial thromboplastin time (PTT)

3. IVY bleeding time 4. Fibrinogen

III. Clinical use of Point-of-Care testing for TraumaA. POC Tests

1. TEG (platelet mapping, V-curve, Rapid TEG) 2. I-stat (ph,pCO2,PO2,HCO3-,BE/BD,iCa2+,Hb/Hct,K+,Gluc.)B. Indications for POC.

1. Massive Transfusion 2. Head Injuries

3. Isolated Coagulopathies from Trauma related events.

IV. Clinical Findings with the TEG A. Native TEG tracings B. Platelet Mapping and effects of drugs and the Interpretations. C. V- curve

Page 3: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Why Do we have a Perfusionist talking about Trauma?

Training ExperienceUse of the TEG in Cardiac Surgery Similarities between Cardiac Surgery/

TraumaLessons learned with TEG in Cardiac SurgeryHow can I make a difference in Trauma

Page 4: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 5: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

THROMBIN

FIBRINOGEN

PLATELETS

Page 6: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Clotting Factors

Thrombin

PlateletsFibrin

Clot

Activation Activation

Plasmin

Clot Breakdown

Platelets

Page 7: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 8: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

• PTT (partial thromboplastin time)

• PT (prothrombin time)

• Platelet Count (CBC)

Page 9: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

aPTT measures the integrity of the intrinsic system (factors XII, XI, VIII, IX) and the common pathway.

Page 10: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Prothrombin time is specific to factors VII, V, X, Prothrombin and Fibrinogen.

Page 11: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

How effective is this test and what does it tell us? •Platelet function•Some of our clotting factors

It is at BEST a very crude haemostatic test.

Not really very accurate test and to many variables.

How is it the test performed?

Page 12: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

TEG: Native TEG Kaolin TEG Heparinase TEG Platelet Mapping

ADP, Arachodonic Acid, Reptilase(XIII) “V” Curve Rapid TEG “Tissue Factor” I-stat: pH,PCO2,PO2,Na,K,iCa,Glu,Hct,Hb,HCO3,BE, SaO2.

Page 13: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 14: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Devolopment and History of the TEG.

1948 Birth of the TEG in Germany Hellmut Harter.1960’s Seen on the surgery front in the USA.Whole blood assay for blood clot analysis.TEG Device:

Page 15: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

BleedingThrombosis

Strength StabilityRate

Page 16: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

TEG Analyzer Whole blood analysis

Initiation of clotClot developmentClot strengthClot lysis

Information generatedCoagulation pathway

functionFibrinogen functionPlatelet functionFibrinolysis

Page 17: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 18: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 19: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Platelet function

Clot strength (G)

Clotting time

Clot kinetic

s Clot stability Clot

breakdown

Time (min)

Am

plitu

de (m

m)

Page 20: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 21: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

US Patent 6,787,363

U.S. Patent 6,787,363

Page 22: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

30 min

Page 23: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

30 min

Page 24: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

30 min

Page 25: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Bleeding Pt

Page 26: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Plain cup

5.8 2.2 59.1 0.0 56.2 6.4 *2.0* *0.4* -1.0 55.0

Heparinase cup

Page 27: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Platelet Function : MA

Normal

Abnormally low platelet function“Low MA”

Abnormally high platelet function“High MA”

6.9 7.7 12.9 29.5 25.0 1.7 0.5 -12.4 0.5

Page 28: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Normal

Secondary fibrinolysisLY30 > 7.5%, CI

>3.0)Primary fibrinolysis(LY30 > 7.5%, CI <

1.0)

5.8 6.0 1.2 74.5 55.5 5.8 63.0 -0.0 63.0

Page 29: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Tracing ComparisonRapid TEG

Kaolin activated(standard TEG)

Native TEG(no activator)

Platelet function (MA) – thrombin generation dependent,not activator dependent…

Page 30: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Trauma Patient: 18 y/o Accidental gunshot

wound to the Left neck.

Page 31: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 32: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Rapid TEG contains Tissue Factor (FIII) (tissuethromboplastin)

Page 33: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 34: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 35: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Rapid TEG

Page 36: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 37: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

V-curve measure of the area under the curve represents the rate and production of Thrombin. Remember THROMBIN is the center of the clotting world.

Page 38: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

•MASSIVE TRANSFUSION PROTOCOL(MASSIVE HEMORRAGE PROTOCOL)

•HEAD INJURIESRich in Tissue Factor (FIII)

•Pregnant MothersRich in Tissue Factor (FIII)

Page 39: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

USE OF R

ECOMBIN

ANT FACTOR F

VIIA

(THESE A

RE OFF L

ABEL USES W

HEN USED IN

TRAUM

A)

Page 40: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional
Page 41: OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional

Any and all question?